Leaflet EURESPAL 2mg / ml syrup

Product code:
W03117002
Quantity:
1
Indicated for:
respiratory inflammation; bronchial symptoms
Route of administration:
oral
Substance:
fenspiride (anti-inflammatory agent)
ATC
R03DX03 — Respiratory system | Other systemic drugs for obstructive airway diseases
Fenspiride is a medication used to treat respiratory conditions such as bronchitis, rhinopharyngitis, and other acute or chronic respiratory diseases. It works by reducing inflammation and mucus hypersecretion, with anti-inflammatory, antiallergic, and bronchodilatory properties.

It is indicated for relieving respiratory symptoms such as cough and breathing difficulties and is available in tablet or syrup form. The dosage and duration of treatment are determined by the doctor based on the patient’s age and condition.

Common side effects include nausea, vomiting, abdominal pain, and drowsiness. Rarely, severe allergic reactions or cardiac issues, such as QT interval prolongation, may occur.

Fenspiride should be used as directed by a doctor. In some countries, its use has been restricted due to the risk of cardiac side effects.

General data about EURESPAL 2mg / ml

Substance:
fenspiride
Date of latest medicines list:
01-07-2020
Product code:
W03117002
Concentration:
2mg / ml
Pharmaceutical form:
syrup
Quantity:
1
Product type:
Original
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Pharmaceutical forms available for fenspiride

Concentrations available for fenspiride

  • 2mg/ml
  • 80mg